Every venture capitalist claims to invest in “teams, not products.” It’s the industry’s most repeated line, and mostly it’s nonsense.
Every venture capitalist claims to invest in “teams, not products.” It’s the industry’s most repeated line, and mostly it’s nonsense.
From a venture investor turned AI builder: how falling costs, rising capability, and concentrated capital have redrawn the startup playbook.
These are companies helping us drink more water, and this is who is funding and acquiring those businesses.
AI’s real fight isn’t about the smartest model — it’s about who controls scarce compute, data and distribution. Preemption vs. proliferation, explained.
Explore what more than a decade of Next Billion-Dollar Startups reveals about founder leadership, venture capital, and enduring startup success.
Explore the three signals behind the 2026 Next Billion-Dollar Startups, from capital efficiency to founder validation and long-term growth.
Learn how Forbes and TrueBridge evaluate private, venture-backed companies to identify the Next Billion-Dollar Startups.
Venture math doesn’t always work. In the health tech space, investors like Dan Galles of Allumia Ventures are questioning whether a fresh playbook is needed.
Retail tech doesn’t get enough venture capital. Investors see slow movers, hard integrations and failed pilots while AI raises the stakes for retailers.